Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
Adiponectin may support cardiometabolic biomarker assessment in obesity; leaves open its therapeutic targeting pending mechanistic clarity.
Sun et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: